Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Synthetic Antibody Neutralizing Gluten in Development

Oliver Spadiut

An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten. . . . → Read More: Synthetic Antibody Neutralizing Gluten in Development

Liquid Biopsy for Solid Tumors Now Available

Blood sample tubes

A test that inspects a patient’s blood sample for characteristic indicators of solid-tumor cancer, and can be part of a comprehensive precision analytics program, is now on the market. . . . → Read More: Liquid Biopsy for Solid Tumors Now Available

App Offers Fast, Inexpensive Urinary Tract Infection Test

Bacterial test app

A system for identifying bacterial infections shows the system’s smartphone app and accompanying lab kit can detect urinary tract infections, including those with sepsis, in about an hour. . . . → Read More: App Offers Fast, Inexpensive Urinary Tract Infection Test

Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses

Cocaine addiction

The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses. . . . → Read More: Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses

Trial Testing Universal Nasal Spray Flu Vaccine in Children

Train pssengers in masks

A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types. . . . → Read More: Trial Testing Universal Nasal Spray Flu Vaccine in Children

NIH Grant Aims to Make Drugs Taste Better, Not Bitter

Dispensing pills

A new award from National Institutes of Health funds a study to identify components in taste bud cells that block bitter taste sensations encountered in some drugs and foods. . . . → Read More: NIH Grant Aims to Make Drugs Taste Better, Not Bitter

Gilead Gains Genome-Editing Hepatitis B Therapy

Hepatitis-B virus

Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver. . . . → Read More: Gilead Gains Genome-Editing Hepatitis B Therapy

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

A.I. to Identify Treatment Drivers for Colorectal Cancer

Data and person graphic

A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer